2021
DOI: 10.21638/spbu11.2021.103
|View full text |Cite
|
Sign up to set email alerts
|

The pathogenesis of pulmonary hypertension — vessel wall ischemia as the driving force in disease initiation and progression

Abstract: Surgeons are not trained to decipher the pathogenesis of diseases, which they operate on. They are used to repair, remove, or replace defective tissues and organs. Yet, we often see typical pathomorphological or pathophysiological phenomena, characteristic of a specific disorder that can only be observed during surgery. Such patterns would not be recognized easily by current imaging techniques, and their visibility would require a living organism. In modern terminology, one could call them “surgical biomarkers… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…Atherosclerosis and hypertension progressing are accelerated in patients with systemic autoimmune disorders accompanied by vasculitis syndrome [ 10 ]. There is a concept which regards vasculitis of vasa vasorum or small periadventitial vessels as a key link of atherogenesis and related cardiovascular disorders [ 11 , 12 , 13 , 14 ]. Excessive systemic action of proinflammatory autacoids may cause the development of CHF, based on the paradigm of systemic non-infectious low-intensity inflammation.…”
Section: Introductionmentioning
confidence: 99%
“…Atherosclerosis and hypertension progressing are accelerated in patients with systemic autoimmune disorders accompanied by vasculitis syndrome [ 10 ]. There is a concept which regards vasculitis of vasa vasorum or small periadventitial vessels as a key link of atherogenesis and related cardiovascular disorders [ 11 , 12 , 13 , 14 ]. Excessive systemic action of proinflammatory autacoids may cause the development of CHF, based on the paradigm of systemic non-infectious low-intensity inflammation.…”
Section: Introductionmentioning
confidence: 99%